Abstract
The present studies have shown that chronic antidepressant treatment with desipramine (DMI), imipramine (IMI) and zimelidine produced behavioral evidence for sub- and supersensitivity depending on 5-HT agonist dose and types of behavior examined. Thus, chronic treatment with all three drugs reduced head twitches induced by a high dose of the 5-HT agonist 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT, 4 mg/kg) while an enhanced response was observed at a low 5-MeO-DMT dose (1 mg/kg) or a low dose of the 5-HT precursor 1-5-hydroxytryptophan (12.5 mg/kg). Chronic ZIM and IMI treatment tended to enhance 5-HT receptor activity as assessed by the induction of hyperlocomotion by a high 5-MeO-DMT dose (4 mg/kg) while they reduced the effect of a low dose (1 mg/kg). Long-term ZIM treatment gave evidence of behavioral subsensitivity to the 5-HT agonist 5-MeO-DMT in avoidance learning, while an enhanced response to 5-MeO-DMT was observed in the tail-flick model. However, chronic ZIM treatment shortened response latency in the tail-flick model suggesting that the net result is a decrease in 5-HT activity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Åberg-Wistedt, A., Jostell, K. G., Ross, S. B. and Westerlund, D. (1981). Effects of zimelidine and desipramine on serotonin and noradrenaline uptake mechanisms in relation to plasma concentrations and therapeutic effects during treatment of depression. Psychopharmacology, 74: 297–305
Agnati, L. F., Fuxe, K., Benfenati, F., Zini, I. and Hökfelt, T. (1983). On the functional role of coexistence of 5-HT and substance P in the bulbospinal 5-HT3 neurons. Substance P reduces affinity and increases density of H-5-HT binding sites. Acta Physiol. Scand., (in press)
Andrews, C. D., Fernando, J. C. R. and Curzon, G. (1982). Differential involvement of dopamine-containing tracts in 5-hydroxytryptamine-dependent behaviors caused by amphetamine in large doses. Neuropharmacology, 21: 63–68
Basbaum A. I. (1981). Descending control of pain transmission: Possible serotonergic enkephalinergic interactions. In B. Harber, S. Gabay, M. R. Issodorides and S. G. A. Alivisatos (eds.), Serotonin. Current Aspects of Neurochemistry and Function, Plenum Press, New York, pp. 177–195
Belcher, G., Ryall, R. W. and Schaffner, R. (1978). The differential effects of 5-hydroxytryptamine, noradrenaline and raphe stimulation on nociceptive and non-nociceptive dorsal horn interneurons in the cat. Brain Res., 151: 307–321
Bennett, J. P. and Snyder, S. H. (1976). Serotonin and lysergic acid diethylamide binding in rat brain membranes. Relationship to postsynaptic serotonin receptors. Mol.Pharmacol. 12: 373–389
Berge, O. G. (1982). Effects of 5-HT receptor agonists and antagonists on a reflex response to radiant heat in normal and spinally transected rats. Pain, 13:253–266
Carlsson, A., Corrodi, H., Fuxe, K. and Hökfelt, T. (1969). Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-α-ethyl-metatyramine. Eur. J. Pharmacol., 5: 357–366
Corne, S., Pickering, R. and Warner, B. (1963). A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine. Br.J.Pharmacol., 20: 106–120
Costa, E. (1982). Perspectives in the molecular mechanisms of antidepressant action. In E. Costa and G. Racagni (eds.), Typical and Atypical Antidepressants: Molecular Mechanisms, Raven Press, New York, pp. 21–26
Friedman, E. and Dallob, A. (1979). Enhanced serotonin receptor activity after chronic treatment with imipramine or amitriptyline. Commun.Psychopharmacol., 3: 89–92
Fuxe, K., Holmstedt, B. and Jonsson, G. (1972). Effects of 5-methoxy-N, N-dimethyltryptamine on central monoamine neurons. Eur.J.Pharmacol., 19: 25–34
Fuxe, K., Ögren, S. O. and Agnati, L. F. (1979). The effects of chronic treatment with the 5-hydroxytryptamine uptake blocker zimelidine on central 5-hydroxytryptamine mechanisms. Evidence for the induction of a low affinity binding site for 5-hydroxytryptamine. Neurosci.Lett., 13: 307–312
Fuxe, K., Ögren, S.-O., Agnati, L. F., Eneroth, P., Holm, A. C. and Andersson, K. (1981). Long-term treatment with zimelidine leads to a reduction in 5-hydroxytryptamine neurotransmission within the central nervous system of the mouse and rat. Neurosci.Lett., 21: 57–62
Fuxe, K., Ögren, S. O., Agnati, L. F., Andersson, K. and Eneroth, P. (1982a). On the mechanism of action of antidepressant drugs: Indications of reductions in 5-HT neurotransmission in some brain regions upon subchronic treatment. In S. Z. Langer, R. Takahashi, T. Segawa and M. Briley (eds.), New Vistas in Depression, Pergamon Press, New York, pp. 49–63
Fuxe, K., Ögren, S.-O., Agnati, L. F., Andersson, K. and Eneroth, P. (1982b). Effects of subchronic antidepressant drug treatment on central serotonergic mechanism in the male rat. In E. Costa, and G. Racagni (eds.), Typical and Atypical Antidepressants: Molecular Mechanisms, Raven Press, New York, pp. 91–107
Fuxe K., Ögren, S. O., Agnati, L. F., Benfenati, F., Cavicchioli, L., Fredholm, B., Andersson, K., Eneroth, P. and Farabegoli, C. (1983a). This book, pp. 35–54
Fuxe, K., Ögren, S. O., Agnati, L. F., Benfenati, F., Fredholm, B., Andersson, K., Zini, I. and Eneroth, P. (1983b). Chronic antidepressant treatment and central 5-HT synapses. J.Neuropharmacol., 22: 389–400
Gage, F. H. and Springer, J. E. (1981). Behavioral assessment of norepinephrine and serotonin function and interaction in the hippocampal formation. Pharmacol. Biochem. Behav., 14: 815–821
Grahame-Smith, D. G. (1971). Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhbitor on 1-tryptophan. J. Neurochem., 18: 1053–10662
Green, A. R. and Grahame-Smith, D. G. (1976). The effects of drugs on the processes regulating the functional activity of brain 5-hydroxytryptamine. Nature, 260: 487–491
Hall, H. and Ögren, S.-O. (1981). Effects of antidepressant drugs on different receptors in the brain. Eur.J.Pharmacol., 70: 393–407
Hökfelt, T., Ljungdahl, A., Steinbusch, H., Verhofstad, A., Nilsson, G., Brodin, F., Pernow, B. and Goldstein, M. (1978). Immunohistochemical evidence of substance P immunoreactivity in some 5-hydroxytryptamine containing neurons in the rat central nervous system. Neurosci., 3: 517–538
Jacobs, B. L. (1976). An animal behavior model for studying central serotonergic synapses. Life Sci., 19: 777–786
Kellar, K. J., Cascio, C. S., Butler, J. A. and Kurtzke, R. N. (1981). Differential effects of electroconvulsive shock and antidepressant drugs on serotonin-2 receptors in rat brain. Eur.J.Pharmacol.: 69: 515–518
Leysen, J. E. (1981) Serotoninergic receptors in brain tissue: properties and identification of various 3H-ligand binding sites in vitro. J.Physiol. (Paris), 77: 351–362
McCall, R. B. and Aghajanian, G. K. (1979). Serotonergic facilitation of facial motoneuron excitation. Brain Res., 169: 11–27
Matthews, W. D. and Smith, C. D. (1980). Pharmacological profile of a model for central serotonin receptor activation. Life Sci., 26: 1397–1403
Menkes, D. B., Aghajanian, G. K. and McCall, R. B. (1980). Chronic antidepressant treatment enhances α-adrenergic and serotonergic responses in the facial nucleus. Life Sci., 27: 45–55
Mogilnicka, E. and Klimeck, V. (1979). Mianserin, danitracen and amitriptyline withdrawal increase the behavioral response of rats to 1–5 hydroxytryptophan. J.Pharm.Pharmacol., 31 (10): 704–705
de Montigny, C. and Aghajanian, G. K. (1978). Tricyclic antidepressants: Longterm treatment increases responsitivity of rat brain forebrain neurons to serotonin. Science, 202: 1303–1306
de Montigny, C., Blier, P., Caillé, G. and Kouassi, E. (1981). Pre- and postsynaptic effects of zimelidine and norzimelidine on the serotoninergic system: single cell studies in the rat. Acta Psychiat. Scan. 63 suppl. 290, 79–90
Ögren, S.O. (1982). Forebrain serotonin and avoidance learning: Behavioral and biochemical studies on the acute effect of p-chloroamphetamine on one-way active avoidance learning in the male rat. Pharmacol. Biochem. Behav., 16: 881–895
Ögren, S.O., Fuxe, K., Agnati, L. F., Gustafsson, J. -Å., Jonsson, G. and Holm, A. C. (1979). Reevaluation of the indoleamine hypothesis of depression. Evidence for a reduction of functional activity of central 5-HT systems by antidepressant drugs. J.Neural Transmission, 46: 85–103
Ögren, S.-O., Fuxe, K., Archer, T., Johansson, G. and Holm, A. C. (1982). Behavioral and biochemical studies on the effects of acute and chronic administration of antidepressant drugs on central serotonergic receptor mechanism. In S. Z. Langer, R. Takahashi, T. Segawa and M. Briley (eds.), New Vistas in Depression, Pergamon Press, New York, pp. 11–19
Ögren, S. O. and Holm, A. C. (1980). Test-specific effects of the 5-HT reuptake inhibitors alaproclate and zimelidine on pain sensitivity and morphine analgesia. J.Neural Transmission, 47: 253–271
Ögren, S.-O., Ross, S. B., Hall, H., Holm, A. C. and Renyi, A. L. (1981). The pharmacology of zimelidine: A 5-HT selective reuptake inhibitor. Acta Psychiat. Scand., 63: suppl. 290, 127–151
Olpe, H. R. and Schellenberg, A. (1981). The sensitivity of cortical neurons to serotonin: Effect of chronic treatment with antidepressants, serotonin-uptake inhibitors and monoamine-oxidase-blocking drugs. J. Neural Transmission, 51: 233–244
Pawlowski, L., Stach, R. and Kacz, D. (1982). Chronic treatment with amitriptyline and zimelidine: Attenuation of serotonininduced changes in light-evoked responses from the occipital cortex. In S. Z. Langer, R. Takahasi, T. Segawa and M. Briley (eds.), New Vistas in Depression, Pergamon Press, New York, pp. 73–80
Peroutka, S. J., Lebovitz, R. M and Snyder, S. H. (1981). Two distinct central serotonin receptors with different physiological functions. Science, 212: 827–829
Peroutka, S. J. and Snyder, S. H. (1980). Regulation of serotonin 5-HT-2 receptors labelled with 3H-spiroperidol by chronic treatment with the antidepressant amitriptyline. J.Pharmacol.Exp.Therapeutics, 215: 582–587
Ross, S. B. and Renyi, A. L. (1977). Inhibition of the neuronal uptake of 5-hydroxytryptamine and noradrenaline in rat brain by (Z)-and (E)-3-(4-bromophenyl)-N, N-dimethyl-3-(3-pyridyl) allylamines and their secondary analogues. Neuropharmacology, 16: 57–63
Savage, D. D., Mendels, J. and Frazer, A. (1980). Monoamine oxidase inhibitors and serotonin uptake inhibitors: Differential effects on 3H-serotonin binding sites in rat brain. J.Pharmacol.Exp.Therapeutics, 212: 259–263
Stolz, J. F. and Marsden, C. A. (1982). Withdrawal from chronic treatment with metergoline, dl-propranolol and amitriptyline enhances serotonin receptor mediated behavior in the rat. Eur.J.Pharmacol., 79, 17–22
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Copyright information
© 1983 The contributors
About this chapter
Cite this chapter
Ögren, SO., Fuxe, K., Berge, O.G., Agnati, L.F. (1983). Effects of chronic administration of antidepressant drugs on central serotonergic receptor mechanisms. In: Usdin, E., Goldstein, M., Friedhoff, A., Georgotas, A. (eds) Frontiers in Neuropsychiatric Research. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-06689-6_7
Download citation
DOI: https://doi.org/10.1007/978-1-349-06689-6_7
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-06691-9
Online ISBN: 978-1-349-06689-6
eBook Packages: MedicineMedicine (R0)